Amarin reported $56.56M in EBITDA for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
DBV Technologies DBVT:US USD -15297000 3.22M
Aerie Pharmaceuticals AERI:US USD -25022000 8.43M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Amarin AMRN:US USD 56.56M 93.4M
AstraZeneca AZN:LN USD 3.6B 404M
Esperion Therapeutics ESPR:US USD -41518000 10.71M
GlaxoSmithKline GSK:LN GBP 3.36B 916M
Halozyme Therapeutics HALO:US USD 112.9M 66.29M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
IONIS PHARMACEUT IONS:US USD -54729000 26.4M
JAZZ PHA JAZZ:US USD 348.04M 65.49M
Nektar Therapeutics NKTR:US USD -34794000 9.48M
Neurocrine Biosciences NBIX:US USD 91.8M 33.2M
Novartis NOVN:VX USD 4.69B 34M
Teva Pharmaceutical Industries TEVA:US USD 1.06B 31M